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Abstract
Cancer is often associated with cachexia, cardiovascular symptoms and autonomic dysregulation. We tested whether
extracardiac cancer directly affects the innervation of left ventricular myocardium. Mice injected with Lewis lung carcinoma
cells (tumor group, TG) or PBS (control group, CG) were analyzed after 21 days. Cardiac function (echocardiography), serum
levels of TNF-a and Il-6 (ELISA), structural alterations of cardiomyocytes and their innervation (design-based stereology) and
levels of innervation-related mRNA (quantitative RT-PCR) were analysed. The groups did not differ in various functional
parameters. Serum levels of TNF-a and Il-6 were elevated in TG. The total length of axons in the left ventricle was reduced.
The number of dense core vesicles per axon profile was reduced. Decreased myofibrillar volume, increased sarcoplasmic
volume and increased volume of lipid droplets were indicative of metabolic alterations of TG cardiomyocytes. In the heart,
the mRNA level of nerve growth factor was reduced whereas that of b1-adrenergic receptor was unchanged in TG. In the
stellate ganglion of TG, mRNA levels of nerve growth factor and neuropeptide Y were decreased and that of tyrosine
hydroxylase was increased. In summary, cancer induces a systemic pro-inflammatory state, a significant reduction in
myocardial innervation and a catabolic phenotype of cardiomyocytes in the mouse. Reduced expression of nerve growth
factor may account for the reduced myocardial innervation.
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Introduction
Cancer cachexia is a complex syndrome clinically manifesting
as progressive loss of body weight with or without decreased food
intake, and it is correlated with a poor prognosis [1]. The
pathological involvement of the heart under these conditions was
described as a new entity by Burch et al. [2] and termed the
‘‘cachectic heart’’. Besides changes in the ECG and decreased
heart size in chest x-rays, the cachectic heart is characterized by
loss of epicardial fat, increase in lipofuscin granules and decrease
in cardiomyocyte cross-sectional area despite generally normal
cardiac function [3,4]. Additionally, protein mass is decreased
resulting from increased protein catabolism [5].
Interestingly, cancer is associated with functional alterations of
the cardiovascular system, such as decreased heart rate variability
in acute leukemia patients [6], increased resting heart rate,
decreased resting blood pressure and increased postural fall in
blood pressure in bronchial carcinoma patients [7], and increased
incidence of cardiovascular autonomic insufficiency as assessed by
a variety of electrocardiographic and clinical tests in breast cancer
patients [8,9]. Recently, a link has been hypothesized between
cancer fatigue syndrome (a combination of dyspnea, exercise
limitation and muscle weakness) and clinically non-overt heart
failure, suggesting the fatigue symptoms to arise from autonomic
dysfunction [10]. Although these studies clearly point to an
involvement of the cardiac innervation in cancer cachexia,
systematic studies on this topic are lacking so far.
The innervation of the ventricles predominantly consists of
postganglionic sympathetic axons although, to a minor extent, also
sensory and postganglionic parasympathetic axons are present
[11,12]. At the light microscopic level, immunohistochemistry is
needed to visualize the unmyelinated cardiac nerve fibers. Each
nerve fiber may consist of one or more axons, the number of which
can only be determined by electron microscopy. Besides the
classical neurotransmitter noradrenaline, sympathetic neurons also
contain neuropeptides that are produced in the perikarya and
stored in vesicular structures that are termed large dense core
vesicles (LDCV). LDCV are anterogradely transported through
the axon and are released upon burst or high frequency firing [13].
In the case of cardiac sympathetic axons, LDCV predominantly
contain neuropeptide Y (NPY) [14].
Here, we hypothesized that cancer cachexia is associated with
qualitative and/or quantitative structural alterations of the
myocardial innervation. In order to test this hypothesis, we used
a mouse model of tumor cachexia and examined its characteristics
with respect to serum cytokine levels and cardiac function. In this
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analysis of the left ventricle and employed design-based stereo-
logical methods to quantify various characteristics of cardiomyo-
cytes and their innervation. In addition, the mRNA expression
levels of various proteins related to cardiac innervation were
quantified in the heart and the stellate ganglion, a major ganglion
supplying sympathetic fibres to the heart.
Results
Animals
From the time point of tumor implantation until the end of the
experiment after 21 days, the TG mice lost 2.3260.82 g of lean
body weight while the mice in CG gained 2.1160.37 g of lean
body weight (p,0.001) validating the mouse model as a model of
tumor cachexia. The tumors themselves had a mean weight of
3.360.57 g. There were no significant differences in the weight of
the left ventricle between the groups, however, the ratio between
left ventricle and body weight was significantly higher in TG due
to the decreased body weight (Table 1).
Echocardiography
Table 2 shows the data obtained by echocardiography in
anesthetized, normothermic mice. None of the parameters differed
significantly between TG and CG indicating a preserved cardiac
function in the tumor group at resting conditions.
TNF-a and Il-6 levels
The serum levels of TNF-a and Il-6 were significantly elevated
in TG compared to CG (Table 3).
Quantitative RT-PCR
In the heart, the expression of the b1-adrenergic receptor was
unchanged in TG vs. CG. In addition, the expression of nerve
growth factor (NGF) was decreased in TG compared with CG.
Expression levels of both TNF receptors (TNF-R1, TNF-R2) were
increased threefold or more, respectively, in TG vs. CG.
In the stellate ganglia of TG, the expression of NPY was
significantly reduced whereas the expression of tyrosine hydrox-
ylase, the rate-limiting enzyme for noradrenalin synthesis, was
increased threefold. NGF was significantly downregulated in
tumor-bearing mice but the changes were less extensive than the
changes in transmitter expression. Both TNF receptors were
significantly enhanced in TG vs. CG (Table 4).
Cardiomyocyte morphology
At the light microscopic level, the myocardium appeared
normal with well-preserved cardiomyocytes, widely opened
capillaries due to perfusion fixation and smooth connective tissue
in the interstitium. There were no signs of cardiac atrophy or
interstitial fibrosis. This observation was supported by the total
volume and number of cardiomyocytes which did not differ
significantly between the groups (Figure 1). At the electron
microscopic level, the two groups showed remarkable differences
with respect to their myofibrils and their sarcoplasm. As depicted
by the representative micrographs and the stereological data, the
volume fraction of myofibrils was significantly reduced whereas
the sarcoplasmic volume fraction was significantly enhanced in
TG (Figure 2). The absolute volume of sarcoplasm was
significantly enhanced whereas the decrease in the total myofibril
volume failed to reach statistical significance (p=0.06), probably
because other factors like cardiomyocyte volume and left
ventricular volume introduce a higher variability into the data.
No differences were observed in the nuclear and mitochondrial
volume density or volume (data not shown). Furthermore, in TG a
higher number of larger sized lipid droplets in the sarcoplasm were
noticed which is reflected by a higher total volume of lipid droplets
in the left ventricle (Figure 2). This increase in lipid droplets,
however, is far too low to explain the increase in total sarcoplasmic
volume.
Lipotoxicity
The biochemical analyses of the triglyceride content confirmed
the increase in lipids in cardiomyocytes. Malondialdehyde and
other thiobarbituric acid reactive substances are highly reactive
compounds that are used as markers for oxidative stress. Using two
tests for measuring these substances, we did not find a significant
difference between CG and TG (Table 5). The end point of the
Table 1. Body and tumor weight.
Control
group
Tumor
group
Body weight at day 0 [g] 20.160.8 20.260.6
Body weight (without tumor) at day 21 [g] 22.260.9 17.961.0**
Tumor weight [g] 0 3.360.6***
Left ventricular weight [mg] 70.562.2 68.061.8
Left ventricle-to-body weight ratio [mg/g] 3.1860.10 3.8160.23**
Legend. Data are expressed as mean 6 standard deviation.
* indicates p,0.05,
**indicates p,0.01,
***indicates p,0.001.
doi:10.1371/journal.pone.0020424.t001
Table 2. Echocardiographic data.
Control group Tumor group
HR [min
21]4 2 5 652 401676
FS [%] 4165.4 4466.1
LvedD [mm] 3.7560.1 3.5060.18
LvesD [mm] 2.2160.25 1.9760.26
PW [mm] 0.6460.03 0.6660.07
SW [mm] 0.6860.03 0.6560.10
Legend. Data are expressed as mean 6 standard deviation. There were no
significant differences between CG and TG. HR=heart rate, FS=fractional
shortening, LvedD=left ventricular end-diastolic diameter, LvesD=left
ventricular end-systolic diameter, PW=posterior wall thickness, SW=septum
thickness.
doi:10.1371/journal.pone.0020424.t002
Table 3. Serum levels of TNF- a and Il-6.
Control group Tumor group
TNF-a [pg/ml] 13.0264.12 28.1161.92***
Il-6 [pg/ml] 10.5862.77 18.4163.93**
Legend. Data are expressed as mean 6 standard deviation.
**indicates p,0.01;
***indicates p,0.001.
doi:10.1371/journal.pone.0020424.t003
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However, caspase activity did not differ between the groups
(Table 5). Additionally, we did not find any morphological
evidence for cardiomyocyte apoptosis by electron microscopy.
Total length and morphology of myocardial axons
Figure 3 shows the morphology of the myocardial innervation
and the stereological data of the axon characterization. The total
length of axons ramifying between the cardiomyocytes was
reduced to less than one half in TG when compared to CG.
However, the relative frequency of nerve fibers with a particular
number of axons did not vary between the groups. There were also
no differences in the size of nerve fiber diameters although there
was a tendency to a more frequent occurrence of axons with
smaller diameters in the tumor mice. Interestingly, the number of
neuropeptide storing LDCV per axon profile were reduced by
about 50% in TG compared with CG.
Discussion
The present study tested the hypothesis that chronic exposure to
a large extracardiac tumor causes structural and functional
alterations of the myocardial innervation in mice. The hypothesis
was based on several reports on functional changes of the heart in
patients suffering from a variety of forms of cancer [6–9] and the
observation of degenerative structural lesions of cardiomyocytes in
cancer cachexia [2]. In agreement with our hypothesis, we
observed a pronounced reduction of the total length of axons
innervating left ventricular cardiomyocytes and the number of
neuropeptide storing organelles, LDCV, in these axons. Further-
more, we observed a decrease of myofibrillar volume but increased
sarcoplasm and lipid droplet volume inside cardiomyocytes. The
structural alterations were accompanied by reduced expression
levels of NGF in heart and stellate ganglion, reduced ganglionic
NPY expression but enhanced tyrosine hydroxylase expression.
Figure 1. Morphology of myocardium. Semithin cross-sections (1 mm thickness) stained with toluidine blue did not show any differences in the
dimensions of cardiomyocytes between control (A) and tumor-bearing mice (B). However, the subcellular organization of cardiomyocytes appeared
less dense in the tumor group. Paraffin longitudinal sections (5–7 mm thickness) stained with Masson-Goldner’s trichrome did not provide evidence
for an enhanced collagen deposition in the tumor-bearing mice (D) as compared to control mice (C). Scale bar for A and B=10 mm. Scale bar for C
and D=20 mm.
doi:10.1371/journal.pone.0020424.g001
Table 4. Relative expression of various innervation-related
targets.
Control group Tumor group
Heart
TNF-R1 160.09 3.5660.19***
TNF-R2 160.09 3.0560.25***
b1-R 160.15 1.1360.27
NGF 160.19 0.4360.43*
Stellate ganglion
TNF-R1 160.03 1.6960.08***
TNF-R2 160.08 1.9360.19***
NGF 160.2 0.6160.09*
NPY 160.24 0.3860.11**
TH 160.19 3.2460.10***
Legend. Data are expressed as mean 6 standard deviation.
*indicates p,0.05,
**indicates p,0.01,
***indicates p,0.001.
TNF-R1=tumor necrosis factor receptor 1, TNF-R2=tumor necrosis factor
receptor 2, b1-R=b1 adrenergic receptor, NGF=nerve growth factor,
NPY=neuropeptide Y, TH=tyrosine hydroxylase.
doi:10.1371/journal.pone.0020424.t004
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been well-established for many years [15] and is known to cause a
significant tumor cachexia [16]. In this study, the time between
implantation of tumor cells and sacrifice of the animals was 21 days;
this duration was sufficient to induce a tumor burden of 12–15% of
total body weight and a cachectic condition simulating the clinical
scenario of cancer cachexia. Despite the changes in body mass the
heartsofTGmicehadasimilarwetmassasthoseofCGmicewhich
contrasts with other studies using solid tumors [17]. These
differences may be due to lower tumor burden, duration of the
experiment,mousestrainor tumorcell type. As discussedbelow,the
stereological results clearly indicate a catabolic phenotype of the
Figure 2. Ultrastructure of cardiomyocytes and nerve fibers. Electron micrographs of myocardium from control (A, C, E) and tumor-bearing
mice (B, D, F). A and B demonstrate the the increased volume of sarcoplasm and the loss of myofibrils in more or less longitudinally sectioned
myocytes. Scale bar=5 mm. C and D clearly show the increase in lipid droplet (ld) size and number in the tumor group in diagonally sectioned
myocytes. Scale bar=1 mm. E and F show nerve fibres containing three axons (asterisk) each. There were no apparent differences in the morphology.
The neighbouring myocytes are more or less transversely cut. Abbreviations: cap=capillary, mf myofibrils, mi=mitochondria.
doi:10.1371/journal.pone.0020424.g002
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mass did not occur. The functional performance of the heart was
assessed by echocardiographic parameters under resting conditions.
Overall, heart function did not differ between CG and TG. This is
in contrast to a recent study on mice inoculated with colon-26
adenocarcinoma cells by Tian and co-workers [17] who reported a
significant decrease in fractional shortening in tumor-bearing mice
compared to control mice. However, their study also showed a
different myocardial morphology including fibrosis and disorgani-
zation of mitochondrial cristae which was not observed in the
present study. Therefore, there seem to exist general differences in
the animal models between their and our study. In accordance with
other studies using the Lewis lung carcinoma [18], we observed a
systemic pro-inflammatory condition as characterized by elevated
serum levels of Il-6 and TNF-a. In human cancer cachexia, a
variety of cytokine levels is elevated with TNF-a being the key
cytokine [19]. The excess cytokines may originate both from tumor
cells and from immune cells being stimulated by direct or indirect
signals of the tumor [19]. Pro-inflammatory cytokines, particularly
TNF-a, areknowntointeract withthenervoussystemand thusmay
influence neuronal metabolism and survival [20–22], however, our
data do not provide a cause-effect relationship between inflamma-
tion and the neuronal phenotype as other pathophysiological events
are present in the tumor cachexia model that might affect the
myocardial innervation (e.g. weight loss).
The key findings of the present study are a reduction in the
myocardial innervation and a decrease in LDCV per axonprofile to
approximately 50% ofcontrolvalues. Thesemorphological data are
well supported and complemented by the qRT-PCR analysis which
demonstrates a decreased expression of NPY in the neurons of the
stellate ganglion while the mRNA levels of tyrosine hydroxylase are
enhanced in TG. In addition, NGF mRNA expression levels were
reduced in heart and stellate ganglion. The decrease in the total
length of axons ramifying between cardiomyocytes is indicative of
atrophicchanges intheautonomicnervoussystem oftheheart.This
new finding confirms our hypothesis and strongly supports the
involvement of the cardiac autonomic nervous system in cancer
disease. A reduction in the total length of axons may originate i)
from a loss of neurons in the ganglion, ii) from a loss of arborisation
of each neuron or iii) from the loss of individual axon length. Our
study shows that the reduction of the total axon length is mainly due
to a decrease in nerve fiber density, not because of a reduced
number of axons per nerve fiber. However, the decreased nerve
fiber density was observed throughout the whole ventricle without
patches of complete denervation. Thus, the result may either
originate from a degenerative process that starts in the periphery of
the axon branches or is based on a structural and/or metabolic
affection of the nerve cell body. Studies in homozygous mice with
nullmutationsinthe NGForthe NGFreceptortyrosinekinasegene
have demonstrated that the maintenance of the neurons and their
arborisation in the sympathetic nervous system depends on the
supply with NGF from the target tissues [23]. The reduced
expression of NGF in heart and stellate ganglion makes it very likely
that a lack of NGFplays a causal role in the reduction of myocardial
innervation. Interestingly, there is also evidence that the metabolic
functions of the neurons are disturbed as indicated by the reduction
in the number of LDCV and the reduced NPY mRNA expression.
In contrast to catecholamine-containing small vesicles, these LDCV
contain neuropeptides which are synthesized in the soma of the
neurons and are anterogradely transported to the periphery of the
axons. In the heart, LDCV mainly contain NPY which has
vasoconstrictory effects and serves trophic functions on cardiomy-
ocytes [24]. It induces cardiomyocyte protein synthesis [25] and
stimulates hypertrophy [26]. The reduction of NPY-containing
LDCV may at least partly be responsible for the reduced content of
myofibrils inside the cardiomyocytes. Interestingly, although NPY
was thought to play a major role in anorexia and cachexia based on
its central reduction in these conditions [16], measurements of NPY
plasma levels in human control and cancer patients did not reveal
differences [27]. Nevertheless, it is still debated whether influencing
this system may attenuate cancer cachexia [28]. The main
neurotransmitter of the sympathetic neurons (noradrenalin) is
synthesized from tyrosine through various steps that are enzymat-
ically catalyzed. The rate-limiting enzyme, tyrosine hydroxylase,
was found to be upregulated in the stellate ganglion in TG
which seems to be a counter-regulatory mechanism to the reduced
innervation of the myocardium. The reduction of axon branches in
the left ventricle may therefore be counterbalanced by enhanced
catecholamine production and thus, may explain why we did not
detect any functional differences under resting conditions. On the
other hand, a completely denervated heart presents a very constant
beat frequency but no functional impairment under rest [29] so that
functional changes associated with loss of or disturbed myocardial
innervation may rather become apparent under stress conditions or
by analysis of specific parameters such as heart rate variability.
Unfortunately, due to the complexity of the model (cardiomyocyte
atrophy, skeletal muscle atrophy, anemia) it is hardly possible to
perform a stress test that would clearly distinguish between changes
in myocardial innervation and other extracardiac facors.
The cardiomyocyte compartment in the tumor mice was mainly
characterized by a reduction of myofibrils, and an increase in
sarcoplasm and lipid droplets. Investigations of the pathology of
human myocardium, obtained from hearts of patients who had
died from cancer cachexia, had demonstrated decreased cross-
sectional area of cardiomyocytes and an increase in lipofuscin
granules [2,3]. Partly due to species differences, these results differ
from those obtained in the present study. For example, in contrast
to humans where age is related with an increasing volume of
lipofuscin, this does not occur to a great extent in murine
cardiomyocytes, probably due to the short life span of mice. The
decreased cross-sectional area of cardiomyocytes as described by
Burch et al. [2] is indicative of cardiac atrophy. However, in our
model there was no decrease in the total volume or number of
cardiomyocytes. This may be due to a more advanced disease state
in the human hearts, to the time course between disease begin and
analysis (21 days in mice versus months or years in humans) and of
course due to differences in the complexity of the disease (no
metastasis in the mouse, only mild cachexia). In rabbits subjected
to cancer cachexia, there were no apoptotic cardiomyocytes in
contrast to other organs where a large amount of cells underwent
apoptosis [30]. At the ultrastructural level, however, a loss of
Table 5. Lipid content, lipid peroxidation and caspase 3/7
activity.
Control
group
Tumor
group
Triglycerides per unit myocardium [mg/mg] 12.1263.75 19.567.91*
MDA adduct per unit protein [pmol/mg] 3.2560.47 3.7760.63
TBARS per unit protein [mM/mg] 1.4460.49 2.0460.73
Caspase 3/7 activity per unit protein [LU/mg] 77.8611.4 91.8614.6
Legend. Data are expressed as mean 6 standard deviation.
MDA=malondialdehyde, TBARS=thiobarbituric acid reactive substances,
LU=luminescence units.
*=p,0.05.
doi:10.1371/journal.pone.0020424.t005
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PLoS ONE | www.plosone.org 5 May 2011 | Volume 6 | Issue 5 | e20424Figure 3. Stereological results. Neither the volume of cardiomyocytes (A, open circles) nor the volume of the interstitial space (A, filled squares)
was different between the groups. In addition, the number of cardiomyocytes was similar among the groups (B). The volume of sarcoplasm (C, filled
squares)was significantly increased in the tumor group while the volume of myofibrils (C, open circles) tended to be smaller. A greater volume of lipid
droplets was found in the cardiomyocytes of tumor-bearing than of control mice (D). Note the logarithmic scale on the y-axis (D). The total length of
axons was reduced to approximately one half in the tumor group (E) while the relative frequency of nerve fibers with a certain number of axons did
not differ between the groups (F). The number of LDVC per axon profile was reduced in the tumor group (G) while the diameter of the axons was
similar in both groups (H). Each circle or square represents the data for an individual animal. The horizontal bars demonstrate the group mean.
doi:10.1371/journal.pone.0020424.g003
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sarcoplasmic volume. The decrease in myofibrils is indicative of an
imbalance between protein degradation and synthesis favouring
protein catabolism [5]. Because of the unchanged volume of
cardiomyocytes the changes in myofibrillar/sarcoplasmic volume
cannot be induced by cellular edema. An interesting structural
observation was the increase in lipid droplets which was confirmed
by biochemical measurements of triglycerides. In tumor cachexia,
fatty acids are released from the adipose tissue and accumulate in
other cell types where they may cause lipotoxic effects [31,32].
Cardiac lipotoxicity involves the generation of reactive oxygen
species and the onset of apoptotic pathways [33]. In the current
analysis, lipid peroxidation was assessed by measuring malondial-
dehyde and associated compounds, and apoptosis was evaluated
by a caspase activity assay and morphological evaluation. Since
none of these parameters was significantly different between TG
and CG, we conclude that the observations of this study are not
related to lipotoxicity. Although the exact functional significance
of the observed ultrastructural alterations of the cardiomyocytes
remains to be investigated, it is very likely that these changes are in
direct relationship to the lack of trophic NPY stimulus via the NPY
Y5 receptor [34] and may become functionally relevant if the
metabolic demand of the heart increases. Due to the relatively
large cardiac plasticity these changes may not necessarily lead to a
significant impairment of cardiac function [35].
In summary, this study for the first time demonstrates that
cancer cachexia is associated with marked structural alterations of
the autonomic innervation of the heart, including both impair-
ment of the structural integrity of the neuron (diminished total
axon length) and organelle loss. Concomitantly, the amount of
lipid and the number and volume of lipid droplets increased in
cardiomyocytes and myofibrillar volume decreased, which is in
line with the concept of a continuous trophic support of
cardiomyocytes by autonomic neurons.
Materials and Methods
Ethics Statement
All the animal experiments were carried out in strict accordance
with the recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol (GZ 66.010/0085-II/10b/2009) was approved by the
Austrian committee on the ethics of animal experiments
(Bundesministerium fu ¨r Wissenschaft und Forschung).
Animals
Female C57BL/6J mice were maintained on a regular light-
dark cycle (12 h light, 12 h dark) and kept on a standard
laboratory chow diet (4.5% w/w fat). Mice used for injection of
tumor cells as well as control animals were 8–9 weeks of age.
During experiments food intake as well as body weight were
monitored daily.
Tumor implantation
Mice were randomly divided into two groups: control non-
tumour-bearing mice (CG, n=18) and mice that were injected
with Lewis lung carcinoma cells (TG, n=18). Carcinoma cells
were maintained in cell culture in DMEM high glucose medium
supplemented with 10% (v/v) FBS, 2 mM L-glutamine and 1%
penicillin-streptomycin. Subsequently, 2610
6 LLC cells, obtained
from an exponentially proliferating cell-culture, were subcutane-
ously injected below the animal’s neck. Sibling mice were injected
with PBS at the same place to serve as sham controls. Both control
and tumor bearing mice were sacrificed after 21 days. In separate
sets of experiments, the mice were used (i) for echocardiography
(n=4 in tumor group, n=5 in control group) and stereology (n=5
in tumor group, n=6 in control group), (ii) for measuring cardiac
lipid content, caspase activity, lipid peroxidation and serum
cytokine levels (n=6 in each group), and (iii) for measuring body,
left ventricular and tumor weight and for polymerase chain
reaction of left ventricle and stellate ganglion (n=6 in each group).
Differences in the number of animals used for echocardiography
and stereology are caused by exclusion of animals that stopped
breathing spontaneously during anesthesia (echocardiography) or
that were not properly fixed by vascular perfusion (stereology).
Echocardiography
2D guided M-mode echoes (30 MHz) were obtained from
short- and long-axis views at the level of the largest LV-diameter
using a VS-VEVO 770 High Resolution Imaging System
(Visualsonics, Toronto, Canada) equipped with a 30 MHz RMV
(Real time microvisualization) scan head. Mice were lightly
anesthetized with 2% isoflurane and were allowed to breathe
spontaneously. The chest was shaved, acoustic coupling gel was
applied, and a warming pad was used to maintain normothermia.
Mice were imaged in a shallow left lateral decubitus position. Left
ventricular end-diastolic and end-systolic dimensions were mea-
sured from original tracings by using the leading edge conventions
of the American Society of Echocardiography. Left ventricular
percent fractional shortening was calculated as previously
described [36].
TNF-a and Il-6 ELISA
Blood samples were taken from anesthetized control and tumor-
bearing mice by retro-orbital puncture. The serum was frozen at
220uC. Serum levels of TNF-a and Il-6 were measured using
TNF-a ELISA ReadySETGo (88-7324, eBiosciences, San Diego,
USA) and Mouse Il-6 ELISA ReadySETGo (88-7064), eBios-
ciences, San Diego, USA). The plate was finally read at 450 nm.
Triglyceride measurement
Triglycerides were extracted from cardiac tissues of control and
tumor-bearing mice using hexane:isopropanol and saponified
using 1% triton-x dissolved in chloroform. The organic solvents
were evaporated using N2 gas and the triglyceride content was
measured using Triglyceride FS kit (Diasys, Germany) according
to the supplier’s manual. The triglyceride levels were normalized
to the tissue weight.
Measurement of lipid peroxidation and caspase activity
To evaluate the presence of lipotoxic effects on cardiomyocytes,
lipid peroxidation was determined by measuring malondialdehyde
and apoptosis was determined by measuring caspase activity.
Cardiac tissue was washed thoroughly with heparin-PBS
solution containing 1 mM EDTA and homogenized in 500 mlo f
homogenization buffer (0.25 M sucrose, 1 mM EDTA, 1 mM
DTT, 1 mM deferoxamine mesylate, 1 mM PMSF) at 4uC.
Protein concentration was determined using RC-DC protein assay
(Bio-Rad, Hercules, CA, USA) from the supernatant. Lipid
peroxidation was measured in the supernatant using the Oxiselect
MDA adduct ELISA kit (STA-332, Cell Biolabs, San Diego, CA,
USA) and TBARS assay (STA-330, Cell Biolabs) according to the
manufacturer’s protocol.
For measurement of caspase 3/7 activity, 15 to 25 mg cardiac
tissue were homogenized in 300 ml of homogenization buffer
(25 mM Hepes pH 7.5, 5 mM EGTA, 1 mM Pefabloc SC, 1%
protease inhibitor cocktail [v/v]) (P8340, Sigma Aldrich, St. Louis,
Myocardial Innervation in Cancer Cachexia
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20 min at 4uC. The supernatant was collected and the protein
content was measured using the DC Protein Assay (Bio-Rad,
Hercules, CA, USA). Caspase activity was determined by
incubating 50 mg protein in 100 ml of Caspase-GloH3/7 reagent
(Promega, Madison, WI, USA) for 1.5 hours at 20uC and
luminescence was determined using a luminometer (LUMIstar
Optima BMG Labtec, Offenburg, Germany).
Quantitative RT-PCR
Total RNA was extracted from the hearts and stellate ganglia of
control and tumor-bearing mice (n=6 each) by the Trizol reagent
(Invitrogen, Carlsbad, California, USA) according to the manu-
facturer’s protocol. One microgram of total RNA was transcribed
reversely into cDNA using the high capacity cDNA reverse
transcription kit (Applied Biosystems, Carlsbad, CA, USA).
Quantitative real-time polymerase chain reaction (qRT-PCR)
was performed using gene specific primers purchased from MWG-
Biotech (Ebersberg, Germany) (Table 6). 18 s RNA was used as
internal control. All reactions were carried out in triplicates.
Quantitative RT-PCR was performed on a 7900T standard rea-
ltime PCR system (Applied Biosystems) using SYBR green as the
detection flurophore. The results are presented as relative
expression levels after calculation based on the delta delta CT
method [37].
Tissue fixation, sampling and processing
After echocardiography, mice were anticoagulated with 500 IE
heparin i.p., anesthetized with isoflurane and killed by cervical
dislocation 3 min later. The heart was then excised, mounted in a
Langendorff apparatus, perfused with 4% paraformaldehyde in
phosphate buffer retrogradely via the aorta for 10 min and kept in
paraformaldehyde at 4uC until further processing. The duration
between fixation and processing was equal for all animals
investigated, thus the potential effect of paraformaldehyde fixation
on immunoreactivity was the same in the control and the
experimental group. The left ventricle including the interventric-
ular septum was separated from the rest of the heart and weighed.
The volume of the left ventricle was calculated by dividing the
mass by the density of muscle tissue, 1.06 g/cm
3 [38]. The isolated
left ventricle was sampled for microscopy as described previously
[39]. In short, eight tissue samples were generated and allocated
for estimation of tissue volume shrinkage, light microscopic or
electron microscopic examination by systematic uniform random
sampling. As several of the stereological analyses performed in this
study require the use of isotropic uniform random samples, the
orientator [40] and the isector method [41] were used to
disorientate the samples for electron and light microscopy,
respectively, and give every orientation of the heart an equal
chance of being selected for the analysis.
The tissue samples for light microscopy were embedded in
paraffin according to standard protocols. The tissue samples for
transmission electron microscopy were osmicated, stained en bloc
in half-saturated aqueous uranyl acetate, dehydrated in an
ascending ethanol series and finally embedded in epoxy resin.
Stereological estimations
The stereological methods used in this study are well-established
and have been the subject of recent reviews [42,43]. Details on
section thickness, staining and magnification are summarized in
Table 7. For light microscopic stereology, an Olympus BX51
microscope (Olympus, Hamburg, Germany), equipped with a
digital camera and the newCAST stereology software (Visio-
pharm, Denmark) was used. Transmission electron microscopy
was performed using a LEO 902 electron microscope (Zeiss,
Oberkochen, Germany). All fields of view for stereological analysis
were obtained by systematic uniform random sampling [44]. The
volume densities of cardiomyocytes and interstitium were
estimated using light microscopy, the volume density of subcellular
cardiomyocyte compartments were estimated by eletron micros-
copy. All volume densities were estimated by the point counting
method (Figure 4) [45]. Briefly, the number of points hitting a
structure of interest (P(str)) was divided by the number of points
hitting the reference volume which provides the volume density (or
fraction) of the structure of interest within the given reference
volume. The total volume of each compartment was calculated
by multiplication of the density by the respective reference volume.
For example, the total volume of mitochondria within cardiomy-
ocytes is calculated by multiplying the volume fraction of mito-
chondria with the volume fraction of cardiomyocytes and the
volume of the left ventricle.
The estimation of the total number of cardiomyocytes was
based, in principle, on the method described by Bru ¨el and
Nyengaard [46]. In short, the numerical density of cardiomyocyte
nuclei was estimated using the optical disector method [47] and
the mean number of nuclei per myocyte was estimated from
40 mm thick paraffin sections immunostained for N-Cadherin
(primary antibody: mouse-anti-pan-cadherin, 1:4000, Sigma;
secondary antibody: peroxidase-labeled goat-anti-mouse IgG)
and peroxidase-labeled wheat germ agglutinin (WGA-Peroxidase,
1:6400, Vector Laboratories, Burlingham, Canada) and subse-
quent 3,3-diaminobenzidine reaction to visualize the borders of
cardiomyocytes [48]. Cardiomyocytes were sampled for this
analysis based on the number of their nuclei using the optical
disector in the middle of the section. If a cardiomyocyte was
sampled, the microscope stage was moved through the whole cell
in the z-direction and the number of nuclei was noted. From the
total number of nuclei and the mean number of nuclei per cell, the
total number of cardiomyocytes was calculated according to
ref. [46].
The total length of axons ramifying between cardiomyocytes
was estimated by a recently established method [49]. Nerve fiber
profiles were visualized by immunohistochemistry for protein gene
product 9.5 (PGP9.5) [50] and counted if they were lying inside
the area of an unbiased counting frame (Figure 5) [51] to obtain
the length density of nerve fibers. According to the stereological
equation LV=2*Q/A, the length density can be calculated from
the number of nerve fibre profiles (Q) and the reference area used
for counting (A). The latter is calculated by multiplying the area of
the counting frame by the number of counting frames. At the
electron microscopic level, systematic uniform randomly sampling
Table 6. Primers used for quantitative RT-PCR.
Target Forward primer Reverse primer
TNF-R1 CGGAAAGAAATGTCCCAGGT GCGTTGGAACTGGTTCTCCT
TNF-R2 CCTCCTGGCCAATATGTGAA ACATGCTTGCCTCACAGTCC
b1-R CTGCTACAACGACCCCAAGT GGCACGTAGAAGGAGACGAC
NGF CATGGGGGAGTTCTCAGTGT TTGATGTCTGTGGCTGTGGT
NPY CATGTGGTGATGGGAAATGA GGTTTCAGGGGATGAGATGA
TH TCAGAGCAGGATACCAAGCA GGGCATCCTCGATGAGACT
Legend. TNF-R1=tumor necrosis factor receptor 1, TNF-R2=tumor necrosis
factor receptor 2, b1-R=b1 adrenergic receptor, NGF=nerve growth factor,
NPY=neuropeptide Y, TH=tyrosine hydroxylase.
doi:10.1371/journal.pone.0020424.t006
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and F). In these images, the number of axon profiles within one
nerve fibre profile was counted and the arithmetic mean number
of axon profiles per nerve fiber profile was calculated. This
parameter was multiplied with the total length of nerve fibers to
obtain the total length of axons in the ventricle. Two additional
morphometric parameters for characterization of the myocardial
innervation were determined: The mean diameter of axons was
measured as the largest diameter orthogonal to the longest axon
profile diameter, and the number of LDCV per axon profile was
counted.
Some of the stereological parameters were obtained from
paraffin embedded sections. During paraffin embedding a high
and unpredictable degree of tissue shrinkage occurs and leads to
false estimations if the densities obtained from the sections are
simply multiplied by the reference volume before embedding [52].
Therefore, from each animal, one tissue block of left ventricular
myocardium was carefully weighed before embedding and its
volume was calculated. Afterwards these tissue blocks were
separately embedded in paraffin and entirely cut into 7 mm thick
sections, and each 10th section was mounted on a glass slide.
Using the Cavalieri principle [44], the area of these sections
was estimated, multiplied by the section thickness and the total
Table 7. Methodological details of stereological parameters.
Parameter Probe Section Staining Magnification
VV(myo/lv), VV(int/lv) Test points (16 points per FOV) Semithin section Richardson’s stain 640
VV(mit/myo), VV(mf/myo),
VV(sp/myo), VV(nuc/myo)
Test points (12 points per FOV) Ultrathin section Uranyl acetate & Lead citrate 64,400
VV(ld/sp) Test points (256 points per FOV) Ultrathin section Uranyl acetate & Lead citrate 620,000
NV(nuc/lv) Optical disector (h=3 mm) 40 mm thick paraffin section Haematoxylin & Eosin 6100
NN(nuc/myo) Optical disector (h=3 mm) 40 mm thick paraffin section Wheat germ agglutinin,
Immunostaining for N-Cadherin
640
LV(nf/lv) Counting frame (Area: 3,000 mm
2)7 mm thick paraffin section Immunostaining for PGP 9.5 640
QQ(ax/nf) Counting frame (Area: 20 mm
2) Ultrathin section Uranyl acetate & Lead citrate 620,000
Tissue volume shrinkage Cavalieri method (a(p)=1.004 mm
2,
100 points)
Serial 7 mm thick paraffin sections Methylene blue 61.25
Legend. VV=volume density, NV=numerical density, LV=length density, myo=cardiomyocytes, int=interstitium, lv=left ventricle, mit=mitochondria, mf=myofibrils,
sp=residual sarcoplasm, nuc=nucleus, ld=lipid droplets, NN(nuc/myo)=mean number of nuclei per myocyte, nf=nerve fiber, QQ(ax/nf)=mean number of axon
profiles per nerve fibre profile, FOV=fields of view, h=height, a(p)=area per point.
doi:10.1371/journal.pone.0020424.t007
Figure 4. Demonstration of the point counting method. A multi-
purpose grid with 10 points (crosses or endpoints of test lines) is
projected on an electron micrograph. The number of points hitting a
structure of interest, e.g. mitochondria (here, 2), is divided by the total
number of points hitting cardiomyocytes (here, 9) to provide the
volume fraction of mitochondria within cardiomyocytes (here, 2/
9=22.22%). The volume fraction is further multiplied by the reference
volume, viz. the total volume of cardiomyocytes, to provide the total
volume of mitochondria in the left ventricle.
doi:10.1371/journal.pone.0020424.g004
Figure 5. Immunohistochemistry of nerve fibers. Nerve fibers
were detected by immunostaining for protein gene product 9.5
(PGP9.5). Scale bar=50 mm. Nerve fibers (arrows) were counted in an
unbiased counting frame. The dashed line is the inclusion line, the
closed line and its extensions represents the exclusion line (see
Methods section).
doi:10.1371/journal.pone.0020424.g005
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embedding and the volume measured before embedding were
used to calculate the tissue shrinkage due to embedding. A factor
correcting for tissue shrinkage was therefore included where
necessary. No such correction was done for samples embedded in
Epon because previous studies had shown that tissue shrinkage in
epoxy resin is less than 5% [39,52].
Statistics
All data are given as mean 6 standard deviation in the tables or
as individual values in the figures. Control and tumor bearing mice
were compared using the nonparametric two-sided Mann-
Whitney U-test for independent samples. Differences were
considered statistically significant if p,0.05.
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